Picard Medical (PMI) Cash from Financing Activities (2024 - 2026)

Picard Medical's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at -$7.5 million for Q1 2026.

• Quarterly Cash from Financing Activities fell 365.42% year-over-year to -$7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.7 million (changed N/A YoY) and the FY2025 annual result came in at $27.1 million, up 130.63% from the prior year.
• Cash from Financing Activities was -$7.5 million for Q1 2026 at Picard Medical, down from $13.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $13.0 million in Q4 2025 and bottomed at -$7.5 million in Q1 2026.
• A 3-year average of $3.6 million and a median of $2.8 million in 2025 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2025 — Cash from Financing Activities jumped 302.63% — and 2026, when it tumbled 365.42%.
• Picard Medical's Cash from Financing Activities stood at $3.2 million in 2024, then surged by 302.63% to $13.0 million in 2025, then slumped by 157.79% to -$7.5 million in 2026.
• Business Quant data shows PMI's Cash from Financing Activities at -$7.5 million in Q1 2026, $13.0 million in Q4 2025, and $8.9 million in Q3 2025.